Literature DB >> 29141864

IL-1β Induces Pathologically Activated Osteoclasts Bearing Extremely High Levels of Resorbing Activity: A Possible Pathological Subpopulation of Osteoclasts, Accompanied by Suppressed Expression of Kindlin-3 and Talin-1.

Takuma Shiratori1,2, Yukari Kyumoto-Nakamura1, Akiko Kukita3, Norihisa Uehara1, Jingqi Zhang1, Kinuko Koda4, Mako Kamiya4, Tamer Badawy1, Erika Tomoda1,5, Xianghe Xu1,3, Takayoshi Yamaza1, Yasuteru Urano4,6, Kiyoshi Koyano2, Toshio Kukita7.   

Abstract

As osteoclasts have the central roles in normal bone remodeling, it is ideal to regulate only the osteoclasts performing pathological bone destruction without affecting normal osteoclasts. Based on a hypothesis that pathological osteoclasts form under the pathological microenvironment of the bone tissues, we here set up optimum culture conditions to examine the entity of pathologically activated osteoclasts (PAOCs). Through searching various inflammatory cytokines and their combinations, we found the highest resorbing activity of osteoclasts when osteoclasts were formed in the presence of M-CSF, receptor activator of NF-κB ligand, and IL-1β. We have postulated that these osteoclasts are PAOCs. Analysis using confocal laser microscopy revealed that PAOCs showed extremely high proton secretion detected by the acid-sensitive fluorescence probe Rh-PM and bone resorption activity compared with normal osteoclasts. PAOCs showed unique morphology bearing high thickness and high motility with motile cellular processes in comparison with normal osteoclasts. We further examined the expression of Kindlin-3 and Talin-1, essential molecules for activating integrin β-chains. Although normal osteoclasts express high levels of Kindlin-3 and Talin-1, expression of these molecules was markedly suppressed in PAOCs, suggesting the abnormality in the adhesion property. When whole membrane surface of mature osteoclasts was biotinylated and analyzed, the IL-1β-induced cell surface protein was detected. PAOCs could form a subpopulation of osteoclasts possibly different from normal osteoclasts. PAOC-specific molecules could be an ideal target for regulating pathological bone destruction.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29141864     DOI: 10.4049/jimmunol.1602035

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

2.  Systemic and local effects of radiotherapy: an experimental study on implants placed in rats.

Authors:  Mariana Raquel da Cruz Vegian; Bruno César Almeida Costa; Gabriela de Fátima Santana-Melo; Fernanda Herrera Costa Godoi; Estela Kaminagakura; Rubens Nisie Tango; Renata Falchete do Prado; Luciane Dias de Oliveira; Claudio Antonio Federico; Sarah de Oliveira Marco Avelino; Rafael Marques Neves; Luana Marotta Reis de Vasconcellos
Journal:  Clin Oral Investig       Date:  2019-06-01       Impact factor: 3.573

3.  Chemokine ligand 28 (CCL28) negatively regulates trabecular bone mass by suppressing osteoblast and osteoclast activities.

Authors:  Rina Iwamoto; Takumi Takahashi; Kazuto Yoshimi; Yuji Imai; Tsuyoshi Koide; Miroku Hara; Tadashi Ninomiya; Hiroaki Nakamura; Kazutoshi Sayama; Akira Yukita
Journal:  J Bone Miner Metab       Date:  2021-03-15       Impact factor: 2.626

Review 4.  Involvement of NF-κB/NLRP3 axis in the progression of aseptic loosening of total joint arthroplasties: a review of molecular mechanisms.

Authors:  Mohamad Qoreishi; Meysam Panahi; Omyd Dorodi; Naser Ghanbari; Saman Shakeri Jousheghan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-04-04       Impact factor: 3.000

5.  Effects of G-Rh2 on mast cell-mediated anaphylaxis via AKT-Nrf2/NF-κB and MAPK-Nrf2/NF-κB pathways.

Authors:  Chang Xu; Liangchang Li; Chongyang Wang; Jingzhi Jiang; Li Li; Lianhua Zhu; Shan Jin; Zhehu Jin; Jung Joon Lee; Guanhao Li; Guanghai Yan
Journal:  J Ginseng Res       Date:  2021-10-13       Impact factor: 5.735

Review 6.  The Impacts of COVID-19 on Musculoskeletal Health.

Authors:  Olatundun D Awosanya; Ushashi C Dadwal; Erik A Imel; Qigui Yu; Melissa A Kacena
Journal:  Curr Osteoporos Rep       Date:  2022-06-20       Impact factor: 5.163

7.  The Hajdu Cheney mutation sensitizes mice to the osteolytic actions of tumor necrosis factor α.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  J Biol Chem       Date:  2019-08-01       Impact factor: 5.157

8.  Tumor- and osteoclast-derived NRP2 in prostate cancer bone metastases.

Authors:  Navatha Shree Polavaram; Samikshan Dutta; Ridwan Islam; Arup K Bag; Sohini Roy; David Poitz; Jeffrey Karnes; Lorenz C Hofbauer; Manish Kohli; Brian A Costello; Raffael Jimenez; Surinder K Batra; Benjamin A Teply; Michael H Muders; Kaustubh Datta
Journal:  Bone Res       Date:  2021-05-14       Impact factor: 13.567

9.  Tumor necrosis factor primes and metal particles activate the NLRP3 inflammasome in human primary macrophages.

Authors:  Eemeli Jämsen; Jukka Pajarinen; Vesa-Petteri Kouri; Antti Rahikkala; Stuart B Goodman; Mikko Manninen; Dan C Nordström; Kari K Eklund; Katariina Nurmi
Journal:  Acta Biomater       Date:  2020-03-17       Impact factor: 8.947

10.  Genetic Determinants for Bacterial Osteomyelitis: A Focused Systematic Review of Published Literature.

Authors:  Xiaoping Xie; Jiangbi Li; Feng Gu; Ke Zhang; Zilong Su; Qiangqiang Wen; Zhenjiang Sui; Pengcheng Zhou; Tiecheng Yu
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.